We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Patients who use social media to plan cosmetic procedures will now access more reliable information thanks to a landmark new initiative.
Latest data shows an increase in travel-associated chikungunya cases compared to the same period last year
From 2026, driving theory tests will include new CPR questions and, for the first time, questions about defibrillators to boost cardiac arrest survival.
The latest heat-health alert (HHA) issued by UKHSA and the Met Office for all regions of England.
UKHSA warns public to be alert to botulism following adverse reactions to cosmetic procedures involving botulinum toxin.
Professor Susan Hopkins is appointed as the new Chief Executive Officer of the UK Health Security Agency (UKHSA).
Due to risk of infection, non-sterile alcohol-free wipes are not appropriate for the treatment of injuries, wounds or on broken skin, nor for cleaning of intravenous lines.
NHS and local authorities begin roll-out of world-first gonorrhoea vaccination programme across the country.
The latest annual report on common animal-associated infections shows more than 1,500 cases of Lyme disease in 2024.
RSV vaccines are 82% effective for older people and 72% for newborns when mothers are vaccinated at least 14 days before birth.
Measles activity has increased since April 2025 and the UKHSA is continuing to oversee the public health risk assessment.
Children aged 1 to 4 years were most affected, as UKHSA reminds the public of simple steps to reduce infection.
The MHRA has now published the government’s response to its public consultation on future routes to market for medical devices - designed to modernise regulation
Information relating to the expansion of Shingrix® vaccine eligibility to all those who are severely immunosuppressed and aged 18 years and over.
UKHSA has appointed Professor Robin May as Interim Chief Scientific Officer.
A new world-leading biosecurity centre in Essex will protect the UK from emerging public health threats and boost economic growth.
New data from UKHSA reveals that treating urinary tract infections (UTIs) cost NHS hospitals in England an estimated £604 million in 2023 to 2024.
UKHSA data shows 85% of parents are confident childhood vaccines are safe, effective and trustworthy.
Both Campylobacter and Salmonella cases show a 17.1% increase from 2023 to 2024.
GLP-1 medicines are licensed for Type 2 diabetes and weight management, and include the branded products Ozempic, Mounjaro and Wegovy
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).